Vimentin and Notch as biomarkers for breast cancer progression

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.3, 2014-01, pp. : 721-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression

By Simpson Natalie

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 959-968

Springer Publishing Company

Access to resources Recommend Favorite

Vimentin DNA methylation predicts survival in breast cancer

By Ulirsch Jacob

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 383-396

Springer Publishing Company

Access to resources Recommend Favorite

Emerging Breast Cancer Biomarkers

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-01 ,pp. : 79-85

Bentham Science Publishers

Access to resources Recommend Favorite

Overexpression of Notch1 is associated with the progression of cervical cancer

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2750-2756

Spandidos Publications

Access to resources Recommend Favorite

Notch: evidence for combining therapies to treat breast cancer

By Leverentz Michael K Acar Ahmet Brennan Keith

Breast Cancer Management, Vol. 2, Iss. 6, 2013-11 ,pp. : 481-488

Future Medicine

Access to resources Recommend Favorite